• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

327.1890 USD 4.7790 1.48%

As of 13:13:09 ET on 01/26/2015.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 323.5600 High - Low: 328.3160 - 321.1500 Primary Exchange: NASDAQ GM
Volume: 778,101 52-Week Range: 207.4800 - 328.3160 Beta vs XNBI: 1.0007

ETF Chart for IBB

No chart data available.
  • IBB:US 327.1890
  • 1D
  • 1M
  • 1Y
322.4100
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE / RENE CASIS
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2015-01-23) 322.5700
Assets (M) (on 2015-01-23) 7,370.7180
Shares out (M) 22.85
Market Cap (M) 7,442.70
% Premium -0.05
Average 52-Week % Premium 0.0088
Fund Leveraged N

Dividends for IBB

Dividend Type Omitted
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.14%

Performance for IBB

1-Month +9.41% 1-Year +27.79%
3-Month +13.68% 3-Year +42.40%
Year To Date +6.28% 5-Year +31.35%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 01/22/2015
Name Position Value % of Total
Biogen Idec Inc 1,753,557 620,145,433 8.783%
Celgene Corp 4,745,804 587,103,413 8.315%
Gilead Sciences Inc 5,378,302 565,474,672 8.009%
Amgen Inc 3,263,875 520,816,534 7.376%
Regeneron Pharmaceuticals Inc 1,082,661 455,594,575 6.453%
Vertex Pharmaceuticals Inc 2,288,599 291,338,653 4.126%
Illumina Inc 1,413,279 274,020,665 3.881%
Alexion Pharmaceuticals Inc 1,384,197 249,598,403 3.535%
Mylan Inc/PA 4,342,329 236,396,391 3.348%
BioMarin Pharmaceutical Inc 1,710,928 163,992,449 2.323%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil